These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31321542)

  • 1. Role of Sphingosine Kinase 1 and Sphingosine-1-Phosphate Axis in Hepatocellular Carcinoma.
    Maceyka M; Rohrbach T; Milstien S; Spiegel S
    Handb Exp Pharmacol; 2020; 259():3-17. PubMed ID: 31321542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of sphingosine-1-phosphate and sphingosine kinase-1 in human tissue samples.
    Visentin B; Reynolds G; Sabbadini R
    Methods Mol Biol; 2012; 874():55-67. PubMed ID: 22528439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma.
    Bao M; Chen Z; Xu Y; Zhao Y; Zha R; Huang S; Liu L; Chen T; Li J; Tu H; He X
    Liver Int; 2012 Feb; 32(2):331-8. PubMed ID: 22098666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1-phosphate signaling pathway in a mouse model of diethylnitrosamine-induced hepatocellular carcinoma.
    Sánchez DI; González-Fernández B; San-Miguel B; de Urbina JO; Crespo I; González-Gallego J; Tuñón MJ
    J Pineal Res; 2017 Jan; 62(1):. PubMed ID: 27696512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence.
    Uranbileg B; Ikeda H; Kurano M; Enooku K; Sato M; Saigusa D; Aoki J; Ishizawa T; Hasegawa K; Kokudo N; Yatomi Y
    PLoS One; 2016; 11(2):e0149462. PubMed ID: 26886371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy.
    Zheng X; Li W; Ren L; Liu J; Pang X; Chen X; Kang D; Wang J; Du G
    Pharmacol Ther; 2019 Mar; 195():85-99. PubMed ID: 30347210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen.
    Schröder M; Richter C; Juan MH; Maltusch K; Giegold O; Quintini G; Pfeilschifter JM; Huwiler A; Radeke HH
    Mol Immunol; 2011 May; 48(9-10):1139-48. PubMed ID: 21435724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival.
    Maiti A; Takabe K; Hait NC
    Cell Signal; 2017 Apr; 32():85-92. PubMed ID: 28108260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling pathways involved in sphingosine kinase activation and sphingosine-1-phosphate release in rat myometrium in late pregnancy: role in the induction of cyclooxygenase 2.
    Serrano-Sanchez M; Tanfin Z; Leiber D
    Endocrinology; 2008 Sep; 149(9):4669-79. PubMed ID: 18723875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and function of sphingosine kinase 2 in diseases.
    Song DD; Zhou JH; Sheng R
    Histol Histopathol; 2018 May; 33(5):433-445. PubMed ID: 29057430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Building a better sphingosine kinase-1 inhibitor.
    Lynch KR
    Biochem J; 2012 May; 444(1):e1-2. PubMed ID: 22533672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine kinase 2 and p62 regulation are determinants of sexual dimorphism in hepatocellular carcinoma.
    Green CD; Brown RDR; Uranbileg B; Weigel C; Saha S; Kurano M; Yatomi Y; Spiegel S
    Mol Metab; 2024 Aug; 86():101971. PubMed ID: 38925249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate.
    Kharel Y; Raje M; Gao M; Gellett AM; Tomsig JL; Lynch KR; Santos WL
    Biochem J; 2012 Oct; 447(1):149-57. PubMed ID: 22747486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer.
    Bao Y; Guo Y; Zhang C; Fan F; Yang W
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 28991193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine Kinase 1 is Associated With Immune Cell-Related Gene Expressions in Human Breast Cancer.
    Tsuchida J; Nagahashi M; Nakajima M; Katsuta E; Rashid OM; Qi Q; Yan L; Okuda S; Takabe K; Wakai T
    J Surg Res; 2020 Dec; 256():645-656. PubMed ID: 32810665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
    Wang S; Liang Y; Chang W; Hu B; Zhang Y
    Med Sci Monit; 2018 Apr; 24():1912-1923. PubMed ID: 29605826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer sphingosine-1-phosphate is associated with phospho-sphingosine kinase 1 and lymphatic metastasis.
    Tsuchida J; Nagahashi M; Nakajima M; Moro K; Tatsuda K; Ramanathan R; Takabe K; Wakai T
    J Surg Res; 2016 Sep; 205(1):85-94. PubMed ID: 27621003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium.
    Tanfin Z; Serrano-Sanchez M; Leiber D
    Cell Signal; 2011 Dec; 23(12):1997-2004. PubMed ID: 21803151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells.
    Tauseef M; Kini V; Knezevic N; Brannan M; Ramchandaran R; Fyrst H; Saba J; Vogel SM; Malik AB; Mehta D
    Circ Res; 2008 Nov; 103(10):1164-72. PubMed ID: 18849324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of small-molecule inhibitors of sphingosine-1-phosphate signaling.
    Edmonds Y; Milstien S; Spiegel S
    Pharmacol Ther; 2011 Dec; 132(3):352-60. PubMed ID: 21906625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.